Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)245-247
Number of pages3
JournalDrug and Alcohol Dependence
Volume185
DOIs
StatePublished - Apr 1 2018

Fingerprint

Substance-Related Disorders
Safety
Varenicline

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

@article{e6d5c3583abf4d968d2e41abaa5cdb14,
title = "Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders",
author = "Shadi Nahvi and Arnsten, {Julia H.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.drugalcdep.2018.02.001",
language = "English (US)",
volume = "185",
pages = "245--247",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders

AU - Nahvi, Shadi

AU - Arnsten, Julia H.

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85055666403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055666403&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2018.02.001

DO - 10.1016/j.drugalcdep.2018.02.001

M3 - Article

C2 - 30369710

AN - SCOPUS:85055666403

VL - 185

SP - 245

EP - 247

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -